6.
Wong D, Holtom P, Spellberg B
. Osteomyelitis Complicating Sacral Pressure Ulcers: Whether or Not to Treat With Antibiotic Therapy. Clin Infect Dis. 2018; 68(2):338-342.
PMC: 6594415.
DOI: 10.1093/cid/ciy559.
View
7.
Falcone M, Meier J, Marini M, Caccialanza R, Aguado J, Del Prato S
. Diabetes and acute bacterial skin and skin structure infections. Diabetes Res Clin Pract. 2021; 174:108732.
DOI: 10.1016/j.diabres.2021.108732.
View
8.
Ince P, Game F, Jeffcoate W
. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area. Diabetes Care. 2007; 30(3):660-3.
DOI: 10.2337/dc06-2043.
View
9.
Bowler P, Davies B, Jones S
. Microbial involvement in chronic wound malodour. J Wound Care. 1999; 8(5):216-8.
DOI: 10.12968/jowc.1999.8.5.25875.
View
10.
Lipsky B, Aragon-Sanchez J, Diggle M, Embil J, Kono S, Lavery L
. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2015; 32 Suppl 1:45-74.
DOI: 10.1002/dmrr.2699.
View
11.
Principe L, Sanson G, Luzzati R, Aschbacher R, Pagani E, Luzzaro F
. Time to reconsider moxifloxacin anti-anaerobic activity?. J Chemother. 2022; 35(4):367-368.
DOI: 10.1080/1120009X.2022.2106637.
View
12.
Lavery L, Armstrong D, Wunderlich R, Mohler M, Wendel C, Lipsky B
. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006; 29(6):1288-93.
DOI: 10.2337/dc05-2425.
View
13.
Markowicz M, Schotta A, Penatzer F, Matscheko C, Stanek G, Stockinger H
. Isolation of from Skin Ulcer after a Tick Bite, Austria, 2020. Microorganisms. 2021; 9(7).
PMC: 8304467.
DOI: 10.3390/microorganisms9071407.
View
14.
Esposito S, Ascione T, Pagliano P
. Management of bacterial skin and skin structure infections with polymicrobial etiology. Expert Rev Anti Infect Ther. 2018; 17(1):17-25.
DOI: 10.1080/14787210.2019.1552518.
View
15.
Dinh M, Abad C, Safdar N
. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis. 2008; 47(4):519-27.
PMC: 7450707.
DOI: 10.1086/590011.
View
16.
Cutting K, White R, Edmonds M
. The safety and efficacy of dressings with silver - addressing clinical concerns. Int Wound J. 2007; 4(2):177-84.
PMC: 7951405.
DOI: 10.1111/j.1742-481X.2007.00338.x.
View
17.
Lipsky B, Berendt A, Cornia P, Pile J, Peters E, Armstrong D
. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012; 54(12):e132-73.
DOI: 10.1093/cid/cis346.
View
18.
Cafaro A, Barco S, Pigliasco F, Russo C, Mariani M, Mesini A
. Therapeutic drug monitoring of glycopeptide antimicrobials: An overview of liquid chromatography-tandem mass spectrometry methods. J Mass Spectrom Adv Clin Lab. 2024; 31:33-39.
PMC: 10831154.
DOI: 10.1016/j.jmsacl.2023.12.003.
View
19.
Esposito S, De Simone G, Gioia R, Noviello S, Pagliara D, Campitiello N
. Deep tissue biopsy vs. superficial swab culture, including microbial loading determination, in the microbiological assessment of Skin and Soft Tissue Infections (SSTIs). J Chemother. 2016; 29(3):154-158.
DOI: 10.1080/1120009X.2016.1205309.
View
20.
Armstrong D, Lavery L, Harkless L
. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998; 21(5):855-9.
DOI: 10.2337/diacare.21.5.855.
View